Editorial
Glioblastoma: an organ-confined disease?
Translational Cancer Research
2022;
11
(8)
:2473-2476
.
(29 August 2022)
Fluorescence visualization as an auxiliary method to detect oral potentially malignant disorders and oral cancer
Translational Cancer Research
2022;
11
(8)
:2477-2479
.
(29 August 2022)
Clinical characteristics of patients simultaneously diagnosed with lung cancer and active pulmonary tuberculosis in countries where tuberculosis is moderately endemic
Translational Cancer Research
2022;
11
(8)
:2480-2482
.
(29 August 2022)
Management of thyroid nodules with indeterminate fine-needle aspiration cytology: histogram analysis of greyscale sonograms and molecular assay of residual tissue from fine-needle aspiration biopsies
Translational Cancer Research
2022;
11
(8)
:2483-2486
.
(29 August 2022)
Original Article
CD13 downregulation mediated by ubenimex inhibits autophagy to overcome 5-FU resistance by disturbing the EMP3/FAK/NF-κB pathway in gastric cancer cells
Translational Cancer Research
2022;
11
(8)
:2487-2500
.
(29 August 2022)
C chemokines are prognostic biomarkers correlated with diverse immune cell infiltrations in clear cell renal cell carcinoma
Translational Cancer Research
2022;
11
(8)
:2501-2522
.
(29 August 2022)
The comparison between albumin-bilirubin grade and Child-Pugh grade for assessing the prognosis of hepatocellular carcinoma after thermal ablation: a propensity score-matched analysis
Translational Cancer Research
2022;
11
(8)
:2523-2535
.
(29 August 2022)
Clinicopathological and prognostic significance of the long non-coding RNA HOTAIR high expression in head and neck squamous cell carcinoma: a systematic review and meta-analysis
Translational Cancer Research
2022;
11
(8)
:2536-2552
.
(29 August 2022)
Tumor-treating fields in combination with sorafenib curtails the growth of colorectal carcinoma by inactivating AKT/STAT3 signaling
Translational Cancer Research
2022;
11
(8)
:2553-2561
.
(29 August 2022)
Construction of miRNA-mRNA network and a nomogram model of prognostic analysis for prostate cancer
Translational Cancer Research
2022;
11
(8)
:2562-2571
.
(29 August 2022)
Effects of gold nanoparticles on normal hepatocytes in radiation therapy
Translational Cancer Research
2022;
11
(8)
:2572-2581
.
(29 August 2022)
Elevated expression of protein-L-isoaspartate O-methyltransferase-1 (PCMT1) in cervical cancer
Translational Cancer Research
2022;
11
(8)
:2582-2590
.
(29 August 2022)
Development of multivariable risk signature based on four immune-related RNA-binding proteins to predict survival and immune status in lung adenocarcinoma
Translational Cancer Research
2022;
11
(8)
:2591-2606
.
(29 August 2022)
Histone methyltransferase KMT2D mediated lipid metabolism via peroxisome proliferator-activated receptor gamma in prostate cancer
Translational Cancer Research
2022;
11
(8)
:2607-2621
.
(29 August 2022)
The identification of hub biomarkers and pathways in lung cancer and prognostic evaluation
Translational Cancer Research
2022;
11
(8)
:2622-2635
.
(29 August 2022)
Detection of circulating tumor cells and evaluation of epithelial-mesenchymal transition patterns of circulating tumor cells in ovarian cancer
Translational Cancer Research
2022;
11
(8)
:2636-2646
.
(29 August 2022)
A novel pyroptosis related genes signature for predicting prognosis and estimating tumor immune microenvironment in lung adenocarcinoma
Translational Cancer Research
2022;
11
(8)
:2647-2659
.
(29 August 2022)
Clinicopathological significance and prognostic value of polypyrimidine tract binding protein 1 (PTBP1) in gastric cancer
Translational Cancer Research
2022;
11
(8)
:2660-2670
.
(29 August 2022)
Clinical characteristics and survival of patients concurrently diagnosed with lung cancer and active pulmonary tuberculosis
Translational Cancer Research
2022;
11
(8)
:2671-2680
.
(29 August 2022)
Prognostic factors in Japanese men with high-Gleason metastatic castration-resistant prostate cancer
Translational Cancer Research
2022;
11
(8)
:2681-2687
.
(29 August 2022)
Identification of ACSL4 as a biomarker and contributor of ferroptosis in clear cell renal cell carcinoma
Translational Cancer Research
2022;
11
(8)
:2688-2699
.
(29 August 2022)
Usefulness of the estimation of physiologic ability and surgical stress (E-PASS) system for prediction of complication and prognosis in hepatocellular carcinoma patients after hepatectomy
Translational Cancer Research
2022;
11
(8)
:2700-2712
.
(29 August 2022)
E2F1 as a potential prognostic and therapeutic biomarker by affecting tumor development and immune microenvironment in hepatocellular carcinoma
Translational Cancer Research
2022;
11
(8)
:2713-2732
.
(29 August 2022)
Prognostic risk factors for T1 thoracic esophageal cancer: a retrospective cohort study
Translational Cancer Research
2022;
11
(8)
:2733-2741
.
(29 August 2022)
Incidence, prognostic factors and survival in bladder cancer patients: a population-based study
Translational Cancer Research
2022;
11
(8)
:2742-2756
.
(29 August 2022)
Efficacy and safety of anlotinib in metastatic adenoid cystic carcinoma: a retrospective study
Translational Cancer Research
2022;
11
(8)
:2757-2766
.
(29 August 2022)
MicroRNA expression profiles in extracellular vesicles and intracellular of AURKA inhibitor-induced senescent neuroblastoma cells
Translational Cancer Research
2022;
11
(8)
:2767-2782
.
(29 August 2022)
Development and validation of a prognostic predictive model of pulmonary spindle cell carcinoma from the surveillance, epidemiology and end results database
Translational Cancer Research
2022;
11
(8)
:2783-2794
.
(29 August 2022)
A LASSO-based survival prediction model for patients with synchronous colorectal carcinomas based on SEER
Translational Cancer Research
2022;
11
(8)
:2795-2809
.
(29 August 2022)
The relationship between Helicobacter pylori and pancreatic cancer: a meta-analysis
Translational Cancer Research
2022;
11
(8)
:2810-2822
.
(29 August 2022)
Diagnostic value of double low-dose targeted perfusion CT imaging for the diagnosis of invasive and preinvasive pulmonary ground-glass nodules: systematic review and meta-analysis
Translational Cancer Research
2022;
11
(8)
:2823-2833
.
(29 August 2022)
Inhibition of autophagy by 3-methyladenine promotes migration and invasion of colon cancer cells through epithelial mesenchymal transformation
Translational Cancer Research
2022;
11
(8)
:2834-2842
.
(29 August 2022)
Bioinformatics analysis and identification of genes and pathways involved in patients with Wilms tumor
Translational Cancer Research
2022;
11
(8)
:2843-2857
.
(29 August 2022)
Risk factors for postoperative portal vein thrombosis in patients with hepatitis B liver cancer and its impact on mortality—a retrospective study
Translational Cancer Research
2022;
11
(8)
:2858-2865
.
(29 August 2022)
Associations of CD34, Ki67, layer of invasion and clinical pathological characteristics, prognosis outcomes in gastrointestinal stromal tumors—a retrospective cohort study
Translational Cancer Research
2022;
11
(8)
:2866-2875
.
(29 August 2022)
Hypoxia upregulates the expression of lncRNA H19 in non-small cell lung cancer cells and induces drug resistance
Translational Cancer Research
2022;
11
(8)
:2876-2886
.
(29 August 2022)
A network pharmacology-based exploration of the active compounds and potential drug targets of Si-Jun-Zi decoction in the treatment of cutaneous squamous cell carcinoma
Translational Cancer Research
2022;
11
(8)
:2887-2901
.
(29 August 2022)
Pan-cancer analysis identifies CDCA3 as a novel prognostic marker associated with immune infiltration in lung adenocarcinoma through bioinformatics analysis
Translational Cancer Research
2022;
11
(8)
:2902-2916
.
(29 August 2022)
Case Report
Extracranial metastasis of glioblastoma with genomic analysis: a case report and review of the literature
Translational Cancer Research
2022;
11
(8)
:2917-2925
.
(29 August 2022)
Male triple negative axillary accessory breast cancer—a case report
Translational Cancer Research
2022;
11
(8)
:2926-2930
.
(29 August 2022)
Durable response to crizotinib in an advanced lung adenocarcinoma patient harboring rare CD47-MET fusion: a case report
Translational Cancer Research
2022;
11
(8)
:2931-2935
.
(29 August 2022)
A case report of vesicovaginal fistula following Bevacizumab without pelvic disease and radiochemotherapy
Translational Cancer Research
2022;
11
(8)
:2936-2939
.
(29 August 2022)
Anlotinib improved the reactive cutaneous capillary endothelial proliferation induced by camrelizumab: a case report
Translational Cancer Research
2022;
11
(8)
:2940-2945
.
(29 August 2022)
Alfentanil and propofol induced anesthesia for patients with huge endotracheal tumor undergoing fiberoptic bronchoscopic interventional therapy: case report
Translational Cancer Research
2022;
11
(8)
:2946-2952
.
(29 August 2022)
Significant efficacy of paclitaxel plus carboplatin (TP) as a neoadjuvant regimen for metaplastic squamous cell carcinoma of the breast: a rare case report and literature review
Translational Cancer Research
2022;
11
(8)
:2953-2959
.
(29 August 2022)
Hemophagocytic lymphohistiocytosis in two patients following treatment with pembrolizumab: two case reports and a literature review
Translational Cancer Research
2022;
11
(8)
:2960-2966
.
(29 August 2022)
Durable clinical response to ALK tyrosine kinase inhibitors in ALK-rearranged non-small cell lung cancer: a case report
Translational Cancer Research
2022;
11
(8)
:2967-2972
.
(29 August 2022)
Complete response by patients with advanced hepatocellular carcinoma after combination immune/targeted therapy and transarterial chemoembolization: two case reports and literature review
Translational Cancer Research
2022;
11
(8)
:2973-2984
.
(29 August 2022)
Primary teratoma of the adrenal gland: a case report
Translational Cancer Research
2022;
11
(8)
:2985-2989
.
(29 August 2022)
Diagnosis and prognostic analysis of skin infiltration in chronic lymphocytic leukemia: a case report and literature review
Translational Cancer Research
2022;
11
(8)
:2990-2995
.
(29 August 2022)
Allogeneic CAR-T bridging to allo-HSCT as a treatment strategy for refractory adult Burkitt’s lymphoma: a case report
Translational Cancer Research
2022;
11
(8)
:2996-3002
.
(29 August 2022)
